Mps Pharmaa Ltd vs Viyash Scientific Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of MPS Pharmaa Ltd is ₹ 1.73 as of 27 Apr 15:30 . The P/E Ratio of MPS Pharmaa Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Viyash Scientific Ltd changed from 62.7 on March 2021 to 150.3 on March 2025 . This represents a CAGR of 19.11% over 5 years The Market Cap of MPS Pharmaa Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Viyash Scientific Ltd changed from ₹ 5983 crore on March 2021 to ₹ 3273 crore on March 2025 . This represents a CAGR of -11.36% over 5 years The revenue of MPS Pharmaa Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Viyash Scientific Ltd for the Dec '25 is ₹ 872.39 crore as compare to the Sep '25 revenue of ₹ 857.76 crore. This represent the growth of 1.71% The ebitda of MPS Pharmaa Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Viyash Scientific Ltd for the Dec '25 is ₹ 148.35 crore as compare to the Sep '25 ebitda of ₹ 178.99 crore. This represent the decline of -17.12% The net profit of MPS Pharmaa Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Viyash Scientific Ltd changed from ₹ 9.06 crore to ₹ 48.52 crore over 7 quarters. This represents a CAGR of 160.89% The Dividend Payout of MPS Pharmaa Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Viyash Scientific Ltd changed from 38.67 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About MPS Pharmaa Ltd

MPS Pharmaa Limited (Formerly known Advik Laboratories Limited) was incorporated in September, 1994.
The Company was promoted in by the Jains along with a group of dedicated professionals.
Presently, it is engaged in the manufacture and sale of pharmaceutical products in India.
It offers ethical, generic, and over the counter drugs in various formulations.
The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. The company commenced commercial production in 1997.

About Viyash Scientific Ltd

Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself.
The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003.

FAQs for the comparison of MPS Pharmaa Ltd and Viyash Scientific Ltd

Which company has a larger market capitalization, MPS Pharmaa Ltd or Viyash Scientific Ltd?

Market cap of MPS Pharmaa Ltd is 3 Cr while Market cap of Viyash Scientific Ltd is 8,918 Cr

What are the key factors driving the stock performance of MPS Pharmaa Ltd and Viyash Scientific Ltd?

The stock performance of MPS Pharmaa Ltd and Viyash Scientific Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for MPS Pharmaa Ltd and Viyash Scientific Ltd?

As of May 4, 2026, the MPS Pharmaa Ltd stock price is INR ₹1.73. On the other hand, Viyash Scientific Ltd stock price is INR ₹204.15.

How do dividend payouts of MPS Pharmaa Ltd and Viyash Scientific Ltd compare?

To compare the dividend payouts of MPS Pharmaa Ltd and Viyash Scientific Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.